Russia’s Health Ministry has announced the launch of serial production of the Yasen intraocular lens, designed for implantation after removal of the clouded natural lens in cataract surgery. The device is manufactured at the Fedorov Eye Microsurgery Centre. The lens is free of charge for citizens under the state guarantees programme, TASS reported, citing the ministry’s press service.
In the first phase, the centre will be able to produce up to 12,000 lenses per year. Production capacity is then planned to double to 25,000 units annually.
The Yasen lens outperforms standard monofocal models in quality. After surgery, the patient may not need to wear glasses. When cataracts are combined with age‑related presbyopia, the lens provides focusing at different distances, and special modifications are available for patients with other conditions.
The device has undergone a full cycle of clinical trials and is ready for widespread use in medical practice. The Health Ministry stressed that serial production will increase access to high‑tech ophthalmic surgery and strengthen the country’s technological sovereignty in ophthalmology.
Earlier, Health Minister Mikhail Murashko announced the inclusion of surgical care for obese patients in the state guarantees programme for free medical care. And in early April, Prime Minister Mikhail Mishustin said the government had also added treatment courses with personalised mRNA vaccines, the peptide vaccine Oncopept, and CAR‑T therapy to the compulsory health insurance programme. Previously, such technologies were available only through research studies or on a commercial basis. The move will expand Russians’ access to these treatment methods.